학술논문

Sequential therapy of metastatic pancreatic ductal adenocarcinoma (PDAC) after failure of gemcitabine plus nab-paclitaxel with either 5-FU/folinic acid (5FU/LV) plus irinotecan (FOLFIRI) followed by 5FU/LV plus oxaliplatin (OFF) or the reverse sequence: The PANTHEON trial (AIO PAK 0116)
Document Type
Journal
Source
ANNALS OF ONCOLOGY; SEP 2022, 33 7, pS1139-pS1139, 1p. Supplement: 7
Subject
Language
English
ISSN
15698041